Related Experiment Video
Updated: Aug 6, 2026

A Model for Encephalomyosynangiosis Treatment after Middle Cerebral Artery Occlusion-Induced Stroke in Mice
Published on: June 22, 2022
Recurrent Stroke - Should We Think Beyond Ischemia? - Case of MOG Encephalitis
Ajay Nathan1, Bharat Rajkumar1, M Kasiviswanathan2
1Department of Medicine, INHS Sanjivani, Kochi, Kerala, India.
Abstract:
Myelin oligodendrocyte glycoprotein (MOG) antibody-associated disease (MOGAD) is a rare autoimmune demyelinating disorder of the central nervous system that can present with varied neurological symptoms. While commonly mistaken for multiple sclerosis or neuromyelitis optica spectrum disorders, MOGAD can also mimic cerebrovascular events, posing a diagnostic challenge. We report a case of a 30-year-old male who initially presented with acute-onset left-sided hemiplegia and right facial palsy, raising suspicion of an ischemic stroke. Despite thrombolysis, his recurrent neurological symptoms, including dysarthria and cerebellar ataxia, prompted further evaluation. Neuroimaging revealed hyperintense lesions in the right hemi-pons and bilateral middle cerebellar peduncles, raising the possibility of a demyelinating disorder. MOG-IgG seropositivity confirmed the diagnosis of MOG encephalitis. The patient responded well to pulse corticosteroid therapy, followed by maintenance immunosuppression with mycophenolate mofetil, and remained asymptomatic on follow-up. This case underscores the importance of considering autoimmune demyelinating disorders in young patients with recurrent neurological deficits and clinico-radiological dissociation. Early recognition and appropriate immunotherapy can prevent unnecessary thrombolysis and improve patient outcomes. Clinicians should maintain a high index of suspicion for MOGAD as a potential stroke mimic in atypical presentations.
Insights
Myelin oligodendrocyte glycoprotein (MOG) antibody-associated disease (MOGAD) can mimic stroke. Early diagnosis and immunotherapy in young adults with MOGAD are crucial for preventing misdiagnosis and improving outcomes.
Area of Science:
- Neurology
- Immunology
- Neuroimmunology
Background:
- Myelin oligodendrocyte glycoprotein (MOG) antibody-associated disease (MOGAD) is a rare autoimmune demyelinating disorder.
- MOGAD presents with diverse neurological symptoms and can be misdiagnosed as multiple sclerosis, neuromyelitis optica spectrum disorders, or cerebrovascular events.
Purpose of the Study:
- To highlight the diagnostic challenges of MOGAD, particularly its mimicry of stroke.
- To emphasize the importance of early recognition and appropriate immunotherapy for MOGAD.
Main Methods:
- Case report of a 30-year-old male with recurrent neurological deficits.
- Clinical presentation, neuroimaging findings (hyperintense lesions in pons and cerebellar peduncles), and MOG-IgG seropositivity.
- Treatment with pulse corticosteroid therapy and maintenance immunosuppression with mycophenolate mofetil.
Main Results:
- The patient initially presented with stroke-like symptoms (hemiplegia, facial palsy) and received thrombolysis.
- Recurrent symptoms and neuroimaging led to the diagnosis of MOG encephalitis.
- The patient showed significant improvement with immunotherapy and remained asymptomatic.
Conclusions:
- MOGAD should be considered in young patients with recurrent neurological deficits and clinico-radiological dissociation.
- Prompt diagnosis and immunotherapy can prevent unnecessary treatments like thrombolysis and improve patient outcomes.
- Clinicians must maintain a high index of suspicion for MOGAD as a stroke mimic in atypical presentations.
Related Concept Videos
Ischemic Stroke ll: Pathophysiology
Ischemic Stroke l: Introduction
Transient Ischemic Attack l: Introduction
Hemorrhagic Stroke ll: Pathophysiology
Hemorrhagic Stroke l: Introduction
Encephalitis ll: Pathophysiology
